Monitoring safety of over the counter drugs

BMJ

Volumn 324, Issue 7334, 2002, Pages 424-

  Wade, Alan G ^a   Walmsley, James ^b   Marshall, Graham ^b   Layton, Deborah ^c   Shakir, Saad A W ^c   Clark, David ^c  

^a CPS Clinical Research Centre   (United Kingdom)

^b The Boots Company PLC   (United Kingdom)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG;

DRUG SAFETY; HUMAN; LETTER; PHARMACEUTICAL CARE; PHARMACY; PRIORITY JOURNAL; SELF MEDICATION; METHODOLOGY; NOTE; PATIENT PARTICIPATION; POSTMARKETING SURVEILLANCE; SAFETY;

CONSUMER PRODUCT SAFETY; DRUGS, NON-PRESCRIPTION; HUMANS; PATIENT PARTICIPATION; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 0037117053     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.324.7334.424     Document Type: Letter

References (7)

1. Clark D, Layton D, Shakir S. Monitoring the safety of over the counter drugs. BMJ 2001; 323: 706–707. (29 September.)
2. Fisher S, Bryant SG. Postmarketing surveillance: accuracy of patient drug attribution judgments. Clin Pharmacol Ther 1990; 48: 102–107.
3. Clark D, Layton D, Shakir S. Monitoring the safety of over the counter drugs. BMJ 2001; 323: 706–707. (29 September.)
4. Schmid B. The safety assessment of over-the-counter products. Arch Toxicol 1995; 17: 305–311.
5. Meyboom RHB, Egberts ACG, Gribnau FWJ, Hekster YA. Pharmacovigilance in perspective. Drug Safety 1999; 21: 429–447.
6. Thomas DHV, Noyce PR. Over the counter drugs. The interface between self medication and the NHS. BMJ 1996; 312: 688–691.
7. Sinclair HK, Bond CM, Hannaford PC. Pharmacovigilance of over-the-counter products based in community pharmacy: a feasible option? Pharmacoepidemiol Drug Safety 1999; 8: 479–491.